4//SEC Filing
Cowan Elvia 4
Accession 0001649094-24-000063
CIK 0001649094other
Filed
Sep 4, 8:00 PM ET
Accepted
Sep 5, 5:15 PM ET
Size
10.7 KB
Accession
0001649094-24-000063
Insider Transaction Report
Form 4
Vaxcyte, Inc.PCVX
Cowan Elvia
SVP, FINANCE
Transactions
- Sale
Common Stock
2024-09-03$107.67/sh−5,000$538,350→ 12,723 total - Exercise/Conversion
Common Stock
2024-09-03$25.92/sh+5,000$129,600→ 17,723 total - Exercise/Conversion
Stock Option (right to buy)
2024-09-03−5,000→ 114,000 totalExercise: $25.92Exp: 2032-08-08→ Common Stock (5,000 underlying) - Tax Payment
Common Stock
2024-09-03$110.15/sh−1,145$126,122→ 11,578 total
Footnotes (3)
- [F1]The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 13, 2023.
- [F2]Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of restricted stock units. No other shares of common stock subject to the restrictions on transfer set forth in a Lock-Up Agreement dated September 4, 2024 were sold by the Reporting Person.
- [F3]1/4 of the shares subject to the option vested on July 1, 2023, and 1/48 of the shares shall vest monthly thereafter, subject to Reporting Person's continuous service with the Issuer through each such date.
Documents
Issuer
Vaxcyte, Inc.
CIK 0001649094
Entity typeother
Related Parties
1- filerCIK 0001960048
Filing Metadata
- Form type
- 4
- Filed
- Sep 4, 8:00 PM ET
- Accepted
- Sep 5, 5:15 PM ET
- Size
- 10.7 KB